Dr James Stuart Mcghee, MD | |
301 Andrews Ave, Lyster Army Health Clinic, Ft Rucker, AL 36362 | |
(334) 255-7387 | |
Not Available |
Full Name | Dr James Stuart Mcghee |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Aerospace Medicine |
Location | 301 Andrews Ave, Ft Rucker, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316929029 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083A0100X | Preventive Medicine - Aerospace Medicine | 0101040960 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr James Stuart Mcghee, MD 301 Andrews Ave, Lyster Army Health Clinic, Ft Rucker, AL 36362 Ph: (334) 255-7387 | Dr James Stuart Mcghee, MD 301 Andrews Ave, Lyster Army Health Clinic, Ft Rucker, AL 36362 Ph: (334) 255-7387 |
News Archive
Cardiologists and heart imaging specialists at 15 medical centers in eight countries, and led by researchers at Johns Hopkins, have enrolled the first dozen patients in a year-long investigation to learn whether the subtle squeezing of blood flow through the inner layers of the heart is better than traditional SPECT nuclear imaging tests and other diagnostic radiology procedures for accurately tracking the earliest signs of coronary artery clogs.
The Cancer Genome Atlas (TCGA) will fund an effort by scientists at The University of Texas M. D. Anderson Cancer Center to siphon buckets of meaningful information from an ocean of data about the aberrant genetics that drive human cancers.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has initiated an open-label Phase 1b safety and dose escalation clinical trial with INNO-206 at the Sarcoma Oncology Center in Santa Monica, California. The clinical trial will include up to 24 patients with advanced solid tumors who have failed standard therapies.
A large international survey of women with a common condition called polycystic ovary syndrome (PCOS), which is characterized by reproductive and metabolic problems, found nearly two in three were dissatisfied with the length of time they waited and the number of healthcare professionals they had to see before they received a diagnosis, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
› Verified 9 days ago